SSA
COLL icon

Schonfeld Strategic Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,932
Closed -$414K – 2294
2025
Q4 		$414K Buy
+8,932
New +$374K ﹤0.01% 1466
2022
Q4 		– Sell
-18,000
Closed -$289K – 2648
2022
Q3 		$289K Buy
+18,000
New +$317K ﹤0.01% 2109
2019
Q1 		– Sell
-130,800
Closed -$2.25M – 1075
2018
Q4 		$2.25M Sell
130,800
-75,000
-36% -$1.28M 0.09% 299
2018
Q3 		$3.03M Buy
+205,800
New +$3.65M 0.13% 209
2017
Q3 		– Sell
-42,931
Closed -$537K – 623
2017
Q2 		$537K Buy
42,931
+25,425
+145% +$251K 0.06% 378
2017
Q1 		$176K Buy
+17,506
New +$260K 0.02% 554

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return